Literature DB >> 18323834

No effect of endogenous TRIM5alpha on HIV-1 production.

Fengwen Zhang, David Perez-Caballero, Theodora Hatziioannou, Paul D Bieniasz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18323834     DOI： 10.1038/nm0308-235

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  23 in total

1.  Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 isoforms.

Authors:  Emilie Battivelli; Julie Migraine; Denise Lecossier; Saori Matsuoka; Danielle Perez-Bercoff; Sentob Saragosti; François Clavel; Allan J Hance
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Cytoplasmic body component TRIM5{alpha} requires lipid-enriched microdomains for efficient HIV-1 restriction.

Authors:  Seiga Ohmine; Ryuta Sakuma; Toshie Sakuma; Tayaramma Thatava; Gonzalo P Solis; Yasuhiro Ikeda
Journal:  J Biol Chem       Date:  2010-09-01       Impact factor: 5.157

3.  African green monkey TRIM5α restriction in simian immunodeficiency virus-specific rhesus macaque effector CD4 T cells enhances their survival and antiviral function.

Authors:  Sumiti Jain; Matthew T Trivett; Victor I Ayala; Claes Ohlen; David E Ott
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

4.  Determinants for the rhesus monkey TRIM5alpha-mediated block of the late phase of HIV-1 replication.

Authors:  Ryuta Sakuma; Seiga Ohmine; Yasuhiro Ikeda
Journal:  J Biol Chem       Date:  2009-12-01       Impact factor: 5.157

5.  Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha.

Authors:  Max W Richardson; Richard G Carroll; Matthew Stremlau; Nikolay Korokhov; Laurent M Humeau; Guido Silvestri; Joseph Sodroski; James L Riley
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

6.  Human TRIM5alpha expression levels and reduced susceptibility to HIV-1 infection.

Authors:  Shamman Sewram; Ravesh Singh; Emil Kormuth; Lise Werner; Koleka Mlisana; S S Abdool Karim; Thumbi Ndung'u
Journal:  J Infect Dis       Date:  2009-06-01       Impact factor: 5.226

7.  A novel aminoacid determinant of HIV-1 restriction in the TRIM5α variable 1 region isolated in a random mutagenic screen.

Authors:  Quang Toan Pham; Maxime Veillette; Alberto Brandariz-Nuñez; Paulina Pawlica; Caroline Thibert-Lefebvre; Nadia Chandonnet; Felipe Diaz-Griffero; Lionel Berthoux
Journal:  Virus Res       Date:  2013-01-25       Impact factor: 3.303

Review 8.  Innate immune recognition and activation during HIV infection.

Authors:  Trine H Mogensen; Jesper Melchjorsen; Carsten S Larsen; Søren R Paludan
Journal:  Retrovirology       Date:  2010-06-22       Impact factor: 4.602

Review 9.  Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha.

Authors:  Hendrik Huthoff; Greg J Towers
Journal:  Trends Microbiol       Date:  2008-10-29       Impact factor: 17.079

10.  The V86M mutation in HIV-1 capsid confers resistance to TRIM5α by abrogation of cyclophilin A-dependent restriction and enhancement of viral nuclear import.

Authors:  Maxime Veillette; Katsiaryna Bichel; Paulina Pawlica; Stefan M V Freund; Mélodie B Plourde; Quang Toan Pham; Carlos Reyes-Moreno; Leo C James; Lionel Berthoux
Journal:  Retrovirology       Date:  2013-02-28       Impact factor: 4.602
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.